ASPR Newsroom

View All Photos

HHS advances development of Ebola vaccine

Studies will prepare vaccine candidate for clinical trials

Under a one-year contract with Profectus BioSciences Inc., headquartered in Baltimore, BARDA will provide approximately $5.8 million in funding, in addition to subject matter expertise and technical assistance, to further develop an experimental Ebola vaccine.
From the ASPR Blog:
Connecting the dots between individuals, community organizations and community health resilience

Communities that are connected before a disaster strikes are more resilient. So, what does a connected community look like? Find out in this week's blog post.
HHS pursues detection tests for influenza

Tests for influenza viruses to improve diagnosis and speed pandemic response

Potential tests to help doctors diagnose influenza sooner and more accurately will advance in development under contracts from ASPR. The tests could help boost influenza pandemic preparedness by increasing diagnostic capabilities in near-patient care settings.
HHS spurs innovation to develop next-generation portable ventilator

Low-cost, user-friendly ventilators needed for pandemics, routine care

HHS will sponsor the advanced development of a next-generation portable ventilator to help fill the need for portable, low-cost, user-friendly and flexible ventilators in a pandemic or other public health emergency.
HHS contracts with Mapp Biopharmaceutical to develop Ebola drug

Work will accelerate drug development and testing
The development of a medication to treat illness from Ebola will be accelerated under a contract with HHS ASPR. This contract supports the government-wide response to the Ebola outbreak in West Africa.